An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
Authors
Keywords
-
Journal
PHARMACOECONOMICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-07
DOI
10.1007/s40273-020-00965-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of Sequential Treatment with Abaloparatide followed by Alendronate vs. Alendronate Monotherapy in Women at Increased Risk of Fracture: a US Payer Perspective
- (2020) Mickael Hiligsmann et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Cost-effectiveness of a multidisciplinary co-management program for the older hip fracture patients in Beijing
- (2020) K. Peng et al. OSTEOPOROSIS INTERNATIONAL
- Cost-Effectiveness of Sequential Treatment with Abaloparatide vs. Teriparatide for United States Women at Increased Risk of Fracture
- (2019) Mickael Hiligsmann et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
- (2019) M. Hiligsmann et al. OSTEOPOROSIS INTERNATIONAL
- Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2019) J. A. Kanis et al. CALCIFIED TISSUE INTERNATIONAL
- Cost-effectiveness of antiosteoporosis strategies for postmenopausal women with osteoporosis in China
- (2019) Na Li et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data
- (2019) L. Cui et al. OSTEOPOROSIS INTERNATIONAL
- Denosumab: A Unique Perspective on Adherence and Cost-effectiveness Compared With Oral Bisphosphonates in Osteoporosis Patients
- (2018) Paige Morizio et al. ANNALS OF PHARMACOTHERAPY
- Review of the guideline of the American College of Physicians on the treatment of osteoporosis
- (2018) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States
- (2018) Quang A. Le et al. ANNALS OF PHARMACOTHERAPY
- Cost-effectiveness of single-dose zoledronic acid for nursing home residents with osteoporosis in the USA
- (2018) Kouta Ito BMJ Open
- Cost-effectiveness analysis of drugs for osteoporosis treatment in elderly Japanese women at high risk of fragility fractures: comparison of denosumab and weekly alendronate
- (2018) Tomohiro Yoshizawa et al. Archives of Osteoporosis
- Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation
- (2018) M. Hiligsmann et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effectiveness of bisphosphonates for prevention of fracture related to glucocorticoid-induced osteoporosis in Malaysia
- (2017) Nurul-Ain Mohd-Tahir et al. International Journal of Rheumatic Diseases
- Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis
- (2017) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
- (2017) Athanasios D Anastasilakis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan
- (2017) K. Moriwaki et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan
- (2017) T. Mori et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA
- (2016) T. Mori et al. OSTEOPOROSIS INTERNATIONAL
- Cost-Minimization Study Comparing Annual Infusion of Zoledronic Acid or Weekly Oral Alendronate in Women With Low Bone Mineral Density
- (2014) Venice Chávez-Valencia et al. JOURNAL OF CLINICAL DENSITOMETRY
- A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis
- (2014) Mickaël Hiligsmann et al. PHARMACOECONOMICS
- The Prevention of Postmenopausal Osteoporotic Fractures: Results of the Health Technology Assessment of a New Antiosteoporotic Drug
- (2014) Chiara de Waure et al. Biomed Research International
- Denosumab: A cost-effective alternative for older men with osteoporosis from a Swedish payer perspective
- (2013) A. Parthan et al. BONE
- A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures
- (2013) L. Si et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis in the European Union: medical management, epidemiology and economic burden
- (2013) E. Hernlund et al. Archives of Osteoporosis
- Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US
- (2013) Anju Parthan et al. Applied Health Economics and Health Policy
- Does the Funding Source Influence the Results in Economic Evaluations?
- (2010) Rachael L. Fleurence et al. PHARMACOECONOMICS
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search